Picture EBD Group Startup Spotlight at BIO-Europe 2023 650x100px

Document › Details

Bicycle Therapeutics plc. (2/28/23). "Press Release: Bicycle Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update". Cambridge & Boston, MA.

	Organisation	Bicycle Therapeutics plc (Nasdaq: BCYC)
	Group	Bicycle Therapeutics (Group)
	Product	BT8009 (Bicycle Therapeutics)
	Product 2	BT5528 (Bicycle Therapeutics)
	Person	Lee, Kevin (Bicycle Therapeutics 201509– CEO before Pfizer + GSK)
	Person 2	Borah, David (Bicycle Therapeutics 202110 VP, Capital Markets + Investor Relations)

Original document
accessed by [iito] on 2023-05-04

Record changed: 2023-07-27

Picture BIO.NRW Greener Manufacutring Show 2023 Köln 650x200px

More documents for Bicycle Therapeutics (Group)

[1] Bicycle Therapeutics plc. (7/18/23). "Press Release: Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Non-Voting Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares". Cambridg...
[2] Bicycle Therapeutics plc. (7/12/23). "Press Release: Bicycle Therapeutics Announces Pricing of $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares". Cambridge & Boston, MA....
[3] Bicycle Therapeutics plc. (7/12/23). "Press Release: Bicycle Therapeutics Announces Proposed $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares". Cambridge & Boston, MA....
[4] Bicycle Therapeutics plc. (6/23/23). "Press Release: Bicycle Therapeutics Appoints Alethia Young as Chief Financial Officer". Cambridge & Boston, MA....
[5] Bicycle Therapeutics plc. (5/10/23). "Press Release: Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology". Berlin, Cambridge & Boston, MA....
[6] Bicycle Therapeutics plc. (5/4/23). "Press Release: Bicycle Therapeutics Announces Collaboration With the German Cancer Research Center, to Discover and Develop Wholly Owned Bicycle® Radio Conjugates for a Range of Oncology Targets". Cambridge & Boston,...
[7] Bicycle Therapeutics plc. (3/28/23). "Press Release: Bicycle Therapeutics Announces a Strategic Collaboration with Novartis to Discover, Develop and Commercialize Bicycle® Radio-Conjugates". Cambridge & Boston, MA....
[8] Owlstone Medical Ltd.. (3/15/23). "Press Release: Owlstone Medical Enters Partnership with Bicycle Therapeutics for the Development of Antigen-Targeted EVOC Probes for Early Cancer Detection". Cambridge....
[9] Bicycle Therapeutics plc. (2/14/23). "Press Release: Bicycle Therapeutics Announces Phase I Dose Escalation Results from Ongoing Phase I/II Study of BT8009". Cambridge & Boston, MA....
[10] Bicycle Therapeutics plc. (1/4/23). "Press Release: Bicycle Therapeutics Announces FDA Fast Track Designation Granted to BT8009 for the Treatment of Adult Patients with Previously Treated Locally Advanced or Metastatic Urothelial Cancer". Cambridge & Bos...

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]